Insider Transactions in Q4 2024 at Lexaria Bioscience Corp. (LEXX)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 03
2024
|
Richard Christopher Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
27,172
+35.21%
|
$54,344
$2.47 P/Share
|
Dec 02
2024
|
Richard Christopher Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
22,828
+50.0%
|
$45,656
$2.24 P/Share
|